Yaz Lawsuit |
| |
Lawyers Represent Women Who Suffered Side Effects After Taking Yaz, Yasmin or Ocella |
| |
Yaz Riskier Than Other Birth Control Pills |
 |
October 14, 2011—All birth control pills carry a risk of adverse events. On average, two to four women per 10,000 on the pill will suffer blood clots. New studies have revealed that the risk with Yaz is two to three times higher.
Four recent independent studies found that Yaz was associated with increased risk of side effects. Two studies funded by Bayer, the manufactuer of Yaz, reported no increased risk. David Rothman, a medical ethicist at Columbia University, questioned the reliability of the company-funded studies and stated they should be viewed "with a lot of suspicion."
Bayer previously has been criticized by the FDA for misleading advertising in the promotion of Yaz. The FDA action resulted in an unprecedented settlement against the company that required it to spend $20 million on advertising to correct misleading claims. |
| |
The History of Yaz, Yasmin and Ocella |
 |
Yasmin first appeared on the market in 2001 for use as an oral contraceptive. In 2006, Bayer Healthcare purchased the company that manufactured Yasmin and began marketing a nearly identical formulation which Bayer named Yaz. Yaz has become the most popular oral contraceptive in the United States, and it is sold worldwide.
In October 2006, the FDA expanded the approved use of Yaz to include treatment for the symptoms of premenstrual dysphonic disorder (PMDD), which is a severe form of PMS. Later, in January 2007, Yaz was further approved to treat acne in women who also wanted a contraceptive medication. |
| |
Blood Clots Caused by Yaz, Yasmin and Ocella |
| |
Clotting within blood vessels is not uncommon and not necessarily dangerous. Clotting is, in fact, essential to the healing process for punctured blood vessels. When a clot grows, however, it may travel to a coronary artery and cause a heart attack, or it may move to the brain and produce a stroke or move to the lungs and result in pulmonary embolism.
Even women who never had a history of abnormal clotting have developed serious—even fatal—medical conditions after taking Yaz, Yasmin and Ocella. |
| |
What You Should Do |
 |
Your Health |
| If you or a loved one has suffered an injury or side effects following use of Yaz, Yasmin or Ocella, promptly consult your physician for an evaluation. |
Your Legal Rights |
| If you have been injured by taking one of these drugs, you may be entitled to compensation. You should act immediately to contact an attorney experienced in matters involving dangerous pharmaceuticals. |
| |
Our Lawyers Can Help |
 |
O'Steen & Harrison, PLC is handling legal claims against the manufacturers of Yaz, Yasmin and Ocella. We invite you to contact us for a free,
confidential consultation about your legal rights.
We represent patients throughout the United States. We can help you, too, wherever you live.
For free answers to your questions about lawsuits against the manufacturers of Yaz, Yasmin and Ocella, please call us toll-free at
1-800-883-8888 or complete this online contact
form. |
|
 |
O'Steen & Harrison, PLC |
300 W. Clarendon Ave., Suite 400
Phoenix, Arizona 85013-3424
800.883.8888
info@vanosteen.com
|
 |
Current Consumer Cases |
|
Contact Us |
|
Why You Should Choose Us |
We have represented thousands of people, including some of the largest and most important injury cases ever
brought in the United States.
In the single largest damages case in the history of the world, our attorneys were selected by the Arizona Attorney
General as the only Arizona law firm to represent the State against American tobacco companies. As a result,
Arizona taxpayers will receive more than three billion dollars to cover the costs of treating tobacco-related
illnesses, maintain educational programs to prevent young people from smoking, and fund other important State
programs. |
Yaz, Yasmin and Ocella News |
Bayer May Have Pitched Birth Control Pill for Unapproved Use • Bloomberg News • November 21, 2011
Attorney for Yaz and Yasmin Patients Asks FDA to Ban the Contraceptive Drugs •
O'Steen & Harrison, PLC • November 8, 2011
FDA Says Yaz and Other Next-Generation Birth Control Drugs Appear to Increase Blood Clot Risk • Associated Press • October 27, 2011
New Studies Find Yaz More Risky Than Other Leading Birth Control Pills • ABC News • October 14, 2011
More Yaz News Stories
|
|